Analgesia-Nociception Index Guided Intraoperative Remifentanil Administration Versus Standard Practice:Evaluation of Perioperative Opioid Use

NCT ID: NCT03498820

Last Updated: 2021-05-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-19

Study Completion Date

2020-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares two groups of patients undergoing a gynecological surgey under general anesthesia: one group in which intraoperative analgesia is guided by the Analgesia-nociception index, and another group in which intraoperative analgesia is managed as in standard practice. The objective is to assess if the Analgesia Nociception Index may result in a decrease in total analgesic drugs consumption, a decrease in post-operative pain and in chronic pain development.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Analgesia Nociception Index

Intraoperative remifentanil administration guided by the Analgesia Nociception Index

Group Type EXPERIMENTAL

Analgesia Nociception Index

Intervention Type DEVICE

: Non invasive monitor based on heart rate variability analysis, assessing the parasympathetic nervous activity

Usual practice

Intraoperative remifentanil administration managed in standard practice

Group Type ACTIVE_COMPARATOR

Remifentanil

Intervention Type DRUG

intravenous short-acting opioid routinely administered during general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Analgesia Nociception Index

: Non invasive monitor based on heart rate variability analysis, assessing the parasympathetic nervous activity

Intervention Type DEVICE

Remifentanil

intravenous short-acting opioid routinely administered during general anesthesia

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ANI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective gynecological surgery under general anesthesia
* Duration of surgery 1-7 hours
* Duration of hospital stay \> 24 hours

Exclusion Criteria

* chronic pain
* chronic analgesic medication
* neurologic disease
* psychiatric disease
* history of addiction
* kidney or liver failure
* allergy to any anesthetic or analgesic drug
* BMI \> 35
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nada SABOURDIN, MD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'Anesthésie-réanimation chirurgicale - Hôpital Trousseau

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P171003J

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oxycodone and Sufentanil for Analgesia in Hip Surgery
NCT03685188 ENROLLING_BY_INVITATION PHASE4
Postoperative and Opioid Free Anesthesia
NCT03316339 TERMINATED PHASE3
Opioid-Free Orthopaedics
NCT04659317 RECRUITING PHASE3